RT Journal Article SR Electronic T1 The CAR-T Therapy Tisagenlecleucel Is Safe in Secondary CNS Lymphoma JF Cancer Discovery JO Cancer Discov FD American Association for Cancer Research SP OF11 OP OF11 DO 10.1158/2159-8290.CD-RW2019-116 VO 9 IS 9 YR 2019 UL http://cancerdiscovery.aacrjournals.org/content/9/9/OF11.abstract AB Tisagenlecleucel has an acceptable safety profile and showed preliminary evidence of CNS efficacy.